GRAIL Earnings
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
140.58+7.97 (+6.01%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GRAIL earnings summary
In its most recent report on Aug 6, 2026 (Q2 2026), GRAL posted EPS of $-2.56. Revenue for the quarter was $44.7 million. Across the last 9 reports, GRAL shares moved an average of 7.5% (in either direction) in the first trading session after results, rising 5 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
GRAL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-2.56 | — | -2.3% |
| May 7, 2026 | — | $-2.29 | — | -3.2% |
| Mar 12, 2026 | — | $-2.37 | — | +8.8% |
| Nov 13, 2025 | — | $-2.46 | — | +17.5% |
| Aug 13, 2025 | — | $-3.18 | — | +5.6% |
| May 14, 2025 | — | $-3.10 | — | +0.7% |
| Mar 5, 2025 | — | $-1.49 | — | -9.5% |
| Nov 13, 2024 | — | $-3.94 | — | +11.5% |
| Aug 13, 2024 | — | $-51.06 | — | -8.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.